Associated Papers
Targeting G1-S-checkpoint-compromised cancers with cyclin A/B RxL inhibitors.
Singh S et al.
Nature, 2025
40836083 (PubMed )
Supplement: 41586_2025_9433_MOESM4_ESM.zip › 2024-07-15654B-s4 › Table_S5_052925.xlsx › Tab_8-zscore_CDK2_C_T
The N-terminal helix of Xenopus cyclins A and B contributes to binding specificity of the cyclin-CDK complex.
Goda T et al.
The Journal of Biological Chemistry, 2001
Select a paper to view details